Effect of astaxanthin in combination with α-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats

Journal of Nutritional Science and Vitaminology

Volumn 54, Issue 4, 2008, Pages 329-334

  Nakano, Masako ^a   Onodera, Aya ^a   Naito, Emi ^a   Tanabe, Miyako ^a   Yajima, Kazue ^a   Takahashi, Jiro ^b   Van Chuyen, Nguyen ^a  

^a JAPAN WOMEN'S UNIVERSITY   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

tocopherol; Ascorbic acid; Astaxanthin; Diabetes; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ASCORBIC ACID; ASTAXANTHIN; LIPID PEROXIDASE; STREPTOZOCIN; ANTIOXIDANT; XANTHOPHYLL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIET THERAPY; KIDNEY FUNCTION; KIDNEY MASS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN URINE LEVEL; RAT; URINARY EXCRETION; ANIMAL; BLOOD; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG COMBINATION; DRUG EFFECT; HISTOLOGY; KIDNEY; LIVER; METABOLISM; ORGAN SIZE; PHYSIOLOGY; RAT STRAIN;

RATTUS;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DRUG THERAPY, COMBINATION; KIDNEY; LIVER; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, INBRED STRAINS; TOCOTRIENOLS; XANTHOPHYLLS;

EID: 59049085364     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.54.329     Document Type: Article

References (33)

1. Ceriello A, Ouatraro A, Giugliano D. 1992. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 9: 297-299.
2. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ. 2003. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52: 864-871.
3. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
4. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. 1996. Oxidative damage to DNA in diabetes mellitus. Lancet 147: 444-445.
5. Hozawa A, Jacobs DR Jr, Steffes MW, Gross MD, Steffen LM, Lee DH. 2006. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163: 929-937.
6. Montonen J, Knekt P, Järvinen R, Reunanen A. 2004. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27: 362-366.
7. Naguib YM. 2000. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 48: 1150-1154.
8. Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T. 2004. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 20: 49-59.
9. Ikeuchi M, Koyama T, Takahashi J, Yazawa K. 2007. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 71: 893-899.
10. Chow CK. 1991. Vitamin E and oxidative stress. Free Radic Biol Med 11: 215-232.
11. Frei B. 1991. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54: 1113S-1118S.
12. Niki E, Saito T, Kawakami A, Kamiya Y. 1984. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J Biol Chem 259: 4177-4182.
13. Gaede P, Poulsen HE, Parving HH, Pedersen O. 2001. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med 18: 756-760.
14. Kedziora-Kornatowska K, Szram S, Kornatowski T, Szadujkis-Szadurski L, Kedziora J, Bartosz G. 2003. Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp Nephrol 95: e134-e143.
15. Horio E Ozaki K, Yoshida A, Makino S, Hayashi Y. 1985. Requirement for ascorbic acid in a rat mutant unable to synthesize ascorbic acid. J Nutr 115: 1630-1640.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
17. Yagi K. 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216.
18. Shibata S, Natori Y, Nishihara T, Tomisaka K, Matsumoto K, Sansawa H, Nguyen VC. 2003. Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol 49: 334-339.
19. Gavazza MB, Catalá A. 2006. The effect of alpha-tocopherol on lipid peroxidation of microsomes and mitochondria from rat testis. Prostaglandins Leukot Essent Fatty Acids 74: 247-254.
20. Kieu NT, Yurie K, Hung NT, Yamamoto S, Chuyen NY. 2002. Simultaneous analysis of retinol, beta-carotene and tocopherol levels in serum of Vietnamese populations with different incomes. Asia Pac J Clin Nutr 11: 92-97.
21. Ueda T, Igarashi O. 1987. New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J Micronutr Anal 3: 185-198.
22. Giugliano D, Ceriello A, Paolisso G. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267.
23. Bell JG, McEvoy J, Tocher DR, Sargent JR. 2000. Depletion of alpha-tocopherol and astaxanthin in Atlantic salmon (Salmo salar) affects autoxidative defense and fatty acid metabolism. J Nutr 130: 1800-1808.
24. Nakagawa K, Kang SD, Park DK, Handelman GJ, Miyazawa T. 1997. Inhibition of beta-carotene and astaxanthin of NADPH-dependent microsomal phospholipid peroxidation. J Nutr Sci Vitaminol 43: 345-355.
25. Nishigaki L Dmitrovskii AA, Miki W, Yagi K. 1994. Suppressive effect of astaxanthin on lipid peroxidation induced in rats. J Clin Biochem Nutr 16: 161-166.
26. Ha H, Kim C, Son Y, Chung MH, Kim KH. 1994. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 16: 271-274.
27. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. 2000. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26: 387-392.
28. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. 1997. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126.
29. Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. 2006. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55: 3112-3120.
30. Stadtman ER. 1991. Ascorbic acid and oxidative inactivation of proteins. Am J Clin Nutr 54: 1125S-1128S.
31. Abou-Seif MA, Youssef AA. 2004. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346: 161-170.
32. Kang JH. 2003. Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal. Mol Cells 15: 194-199.
33. Kapsokefalou M, Miller DD. 2001. Iron loading and large doses of intravenous ascorbic acid promote lipid peroxidation in whole serum in guinea pigs. Br J Nutr 85: 681-687.